-
Je něco špatně v tomto záznamu ?
The possibility of using the specific RIA method for the area-under-time-concentration curve sparse sampling calculation of cyclosporin A despite a large post-dose overestimation
M. Grundmann, B. Koristkova, H. Brozmanova, I. Perinova, K. Safarcik
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
21176722
DOI
10.5414/cpp49030
Knihovny.cz E-zdroje
- MeSH
- cyklosporin farmakokinetika MeSH
- dospělí MeSH
- imunosupresiva farmakokinetika MeSH
- lidé středního věku MeSH
- lidé MeSH
- lineární modely MeSH
- plocha pod křivkou MeSH
- radioimunoanalýza metody MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVE: To find limited sampling strategies (LSS) for prediction of the real AUC using the RIA analytical method. METHOD: Blood samples of 40 male renal transplant patients taken pre-dose and after 0.5, 1, 1.5, 2, 3, 5, 8, and 12 h in the steady-state were analyzed with HPLC and the specific RIA method. I. Eight equations for AUC0-12 and one for AUC0-8 obtained from the literature, that produced the mean percentage prediction error (%PE) < ± 15% and absolute %PE < 30% in 95% of predictions, were analyzed for possibility to predict the real AUC of CsA. II. Multiple regression analysis (MRA) was provided for the AUC equation proposal. Patients were divided into two groups according to the AUC0-12. Group I was used for LSS : s proposals while Group II for validation. The bias and precision were expressed as %PE, r2 and RMSE. The relationship of %PE interassay and with LSS:s was expressed as Pearson correlation r. GraphPad InStatt Software was used for MRA and Pearson r calculation. RESULTS: None of the equations described in the literature predicts AUC of CsA proprietarily. Seven equations for AUC0-12 and five for AUC0-8 were proposed with MRA for prediction of real AUC from RIA values. CONCLUSIONS: LSS:s can moderate the interassay %PE in AUC of CsA. New patients should be tested with both RIA and HPLC for the level of overestimation. The conversion factors should be calculated for patients with an overestimation higher than 90%. Our equation 251.09 + 0.5195 × C1h + 4.926 × C3h or 196.13 + 4.526 Â× C0h + 2.089 × C1.5h for AUC0-12, and 171.80 + 0.4759 × C1h + 4.132 × C3h for AUC0-8 may be used in patients with medium or low RIA and HPLC differences. Repeated analysis with HPLC is thus suggested in cases with AUC:s results close to the lower or upper margin of the therapeutic window.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12026580
- 003
- CZ-PrNML
- 005
- 20160228070638.0
- 007
- ta
- 008
- 120816s2011 gw f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.5414/cpp49030 $2 doi
- 035 __
- $a (PubMed)21176722
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Grundmann, Milan, $d 1939- $7 nlk20010093222 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
- 245 14
- $a The possibility of using the specific RIA method for the area-under-time-concentration curve sparse sampling calculation of cyclosporin A despite a large post-dose overestimation / $c M. Grundmann, B. Koristkova, H. Brozmanova, I. Perinova, K. Safarcik
- 520 9_
- $a OBJECTIVE: To find limited sampling strategies (LSS) for prediction of the real AUC using the RIA analytical method. METHOD: Blood samples of 40 male renal transplant patients taken pre-dose and after 0.5, 1, 1.5, 2, 3, 5, 8, and 12 h in the steady-state were analyzed with HPLC and the specific RIA method. I. Eight equations for AUC0-12 and one for AUC0-8 obtained from the literature, that produced the mean percentage prediction error (%PE) < ± 15% and absolute %PE < 30% in 95% of predictions, were analyzed for possibility to predict the real AUC of CsA. II. Multiple regression analysis (MRA) was provided for the AUC equation proposal. Patients were divided into two groups according to the AUC0-12. Group I was used for LSS : s proposals while Group II for validation. The bias and precision were expressed as %PE, r2 and RMSE. The relationship of %PE interassay and with LSS:s was expressed as Pearson correlation r. GraphPad InStatt Software was used for MRA and Pearson r calculation. RESULTS: None of the equations described in the literature predicts AUC of CsA proprietarily. Seven equations for AUC0-12 and five for AUC0-8 were proposed with MRA for prediction of real AUC from RIA values. CONCLUSIONS: LSS:s can moderate the interassay %PE in AUC of CsA. New patients should be tested with both RIA and HPLC for the level of overestimation. The conversion factors should be calculated for patients with an overestimation higher than 90%. Our equation 251.09 + 0.5195 × C1h + 4.926 × C3h or 196.13 + 4.526 Â× C0h + 2.089 × C1.5h for AUC0-12, and 171.80 + 0.4759 × C1h + 4.132 × C3h for AUC0-8 may be used in patients with medium or low RIA and HPLC differences. Repeated analysis with HPLC is thus suggested in cases with AUC:s results close to the lower or upper margin of the therapeutic window.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a plocha pod křivkou $7 D019540
- 650 _2
- $a cyklosporin $x farmakokinetika $7 D016572
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunosupresiva $x farmakokinetika $7 D007166
- 650 _2
- $a lineární modely $7 D016014
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a radioimunoanalýza $x metody $7 D011863
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kořístková, Blanka $7 xx0263946 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Brozmanová, Hana $7 xx0103852 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Peřinová, Ilona, $d 1975- $7 xx0094982 $u Department of Clinical Pharmacology, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic
- 700 1_
- $a Šafarčík, Kristian, $7 mzk2006363477 $u Nuclear Medicine Clinic, Ostrava University Hospital and Medical Faculty, University of Ostrava, Ostrava, Czech Republic $d 1950-
- 773 0_
- $w MED00002304 $t International journal of clinical pharmacology and therapeutics $x 0946-1965 $g Roč. 49, č. 1 (2011), s. 30-37
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21176722 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120816 $b ABA008
- 991 __
- $a 20160228070648 $b ABA008
- 999 __
- $a ok $b bmc $g 948622 $s 783926
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 49 $c 1 $d 30-37 $i 0946-1965 $m International journal of clinical pharmacology and therapeutics $n Int J Clin Pharmacol Ther $x MED00002304
- LZP __
- $b NLK122 $a Pubmed-20120816/11/01